Total Payments
$1.1M
2024 Payments
$67,289
Companies
17
Transactions
1,966
Payment Breakdown by Category
Other$885,235 (80.4%)
Travel$133,558 (12.1%)
Consulting$61,425 (5.6%)
Food & Beverage$18,490 (1.7%)
Research$2,809 (0.3%)
Education$84.23 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $871,694 | 487 | 79.1% |
| Travel and Lodging | $133,558 | 912 | 12.1% |
| Consulting Fee | $61,425 | 26 | 5.6% |
| Food and Beverage | $18,490 | 503 | 1.7% |
| Honoraria | $13,541 | 15 | 1.2% |
| Unspecified | $2,809 | 19 | 0.3% |
| Education | $84.23 | 4 | 0.0% |
Payments by Type
General
$1.1M
1,947 transactions
Research
$2,809
19 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $391,527 | 578 | $0 (2024) |
| Allergan, Inc. | $273,130 | 653 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $151,158 | 240 | $0 (2021) |
| Takeda Pharmaceuticals America, Inc. | $97,929 | 133 | $0 (2017) |
| Axsome Therapeutics, Inc. | $81,306 | 114 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $68,442 | 156 | $0 (2018) |
| Eisai Inc. | $18,473 | 36 | $0 (2021) |
| IDORSIA PHARMACEUTICALS US INC | $10,101 | 14 | $0 (2023) |
| Shire North American Group Inc | $6,489 | 10 | $0 (2018) |
| ACADIA Pharmaceuticals Inc | $1,790 | 12 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $67,289 | 97 | ABBVIE INC. ($39,906) |
| 2023 | $190,964 | 281 | AbbVie Inc. ($140,019) |
| 2022 | $150,102 | 215 | ABBVIE INC. ($136,248) |
| 2021 | $94,260 | 154 | AbbVie Inc. ($74,336) |
| 2020 | $62,967 | 132 | Allergan, Inc. ($58,804) |
| 2019 | $120,469 | 285 | Allergan Inc. ($95,479) |
| 2018 | $161,853 | 295 | Takeda Pharmaceuticals U.S.A., Inc. ($120,992) |
| 2017 | $253,696 | 507 | Allergan Inc. ($101,234) |
All Payment Transactions
1,966 individual payment records from CMS Open Payments — Page 1 of 79
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/25/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/24/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/24/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Consulting Fee | Cash or cash equivalent | $2,250.00 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/24/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Travel and Lodging | Cash or cash equivalent | $223.11 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/24/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Travel and Lodging | Cash or cash equivalent | $215.65 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/24/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | Cash or cash equivalent | $12.29 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,125.00 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: Psychology/Psychiatric | ||||||
| 09/26/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $31.82 | General |
| Category: Psychology/Psychiatric | ||||||
| 09/26/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | Cash or cash equivalent | $25.00 | General |
| Category: Psychology/Psychiatric | ||||||
| 09/26/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Travel and Lodging | Cash or cash equivalent | $13.40 | General |
| Category: Psychology/Psychiatric | ||||||
| 09/24/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: Psychology/Psychiatric | ||||||
| 09/24/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | Cash or cash equivalent | $24.79 | General |
| Category: Psychology/Psychiatric | ||||||
| 09/24/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Travel and Lodging | Cash or cash equivalent | $8.71 | General |
| Category: Psychology/Psychiatric | ||||||
| 09/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $31.97 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.36 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $8.04 | General |
| Category: NEUROSCIENCE | ||||||
| 08/16/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| Category: Psychology/Psychiatric | ||||||
| 08/16/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Travel and Lodging | Cash or cash equivalent | $341.70 | General |
| Category: Psychology/Psychiatric | ||||||
| 08/16/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | Cash or cash equivalent | $24.23 | General |
| Category: Psychology/Psychiatric | ||||||
| 08/16/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $8.23 | General |
| Category: Psychology/Psychiatric | ||||||
| 07/24/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | Cash or cash equivalent | $120.52 | General |
| Category: SCHIZOPHRENIA | ||||||
| 06/18/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $6.28 | General |
| Category: Psychology/Psychiatric | ||||||
| 05/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,975.00 | General |
| Category: NEUROSCIENCE | ||||||
| 05/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,125.00 | General |
| Category: NEUROSCIENCE | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| ACP-103-059/ACP-103-055 | ACADIA Pharmaceuticals Inc | $1,790 | 12 |
| M16-100 | AbbVie, Inc. | $1,018 | 7 |
About Dr. Thomas Weiss, MD
Dr. Thomas Weiss, MD is a Psychiatry healthcare provider based in San Antonio, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/11/2005. The National Provider Identifier (NPI) number assigned to this provider is 1063414928.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Weiss, MD has received a total of $1.1M in payments from pharmaceutical and medical device companies, with $67,289 received in 2024. These payments were reported across 1,966 transactions from 17 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($871,694).
Ad
Practice Information
- Specialty Psychiatry
- Location San Antonio, TX
- Active Since 08/11/2005
- Last Updated 12/28/2011
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1063414928
Products in Payments
- VRAYLAR (Drug) $569,328
- Trintellix (Drug) $248,767
- NAMZARIC (Drug) $94,257
- Auvelity (Drug) $81,278
- BELSOMRA (Drug) $68,442
- Dayvigo (Drug) $18,473
- QUVIVIQ (Drug) $10,101
- VYVANSE (Drug) $2,312
- NUPLAZID (Drug) $1,790
- Androgel (Drug) $1,018
- CAPLYTA (Drug) $249.97
- REXULTI (Drug) $247.13
- Entyvio (Biological) $196.20
- Austedo XR (Drug) $139.46
- ABILIFY MAINTENA (Drug) $125.00
- TRINTELLIX (Drug) $123.97
- FANAPT (Drug) $120.52
- AUSTEDO (Drug) $114.28
- VIBERZI (Drug) $54.45
- Sunosi (Drug) $27.58
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in San Antonio
Dr. Nathan Johnston
Psychiatry — Payments: $170,581
Psychiatry $170,581
Dr. Damaso Oliva, M.d, M.D
Psychiatry — Payments: $143,531
Psychiatry $143,531
Jair Soares, M.d, M.D
Psychiatry — Payments: $65,345
Psychiatry $65,345
Dr. Rosario Rodriguez, Md, MD
Psychiatry — Payments: $48,083
Psychiatry $48,083
James Redmond, M.d, M.D
Psychiatry — Payments: $42,570
Psychiatry $42,570
Christopher Ticknor, Md, MD
Psychiatry — Payments: $41,170
Psychiatry $41,170